WIF1 causes dysfunction of heart in transgenic mice

Transgenic Research

Volumn 22, Issue 6, 2013, Pages 1179-1189

  Lu, Dan ^a   Dong, Wei ^a   Zhang, Xu ^a   Quan, Xiongzhi ^a   Bao, Dan ^a   Lu, Yingdong ^a   Zhang, Lianfeng ^a,b  

^a BEIJING HOSPITAL   (China)

^b INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

Author keywords

Heart; Mice; Transgene; WIF1

Indexed keywords

MUS; MUS MUSCULUS;

ACTIN; BETA CATENIN; BRAIN NATRIURETIC PEPTIDE; SCLEROPROTEIN; SIGNAL PEPTIDE; TROPONIN T; WIF1 PROTEIN, MOUSE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CONGENITAL HEART MALFORMATION; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETICS; HEART; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PROMOTER REGION; TRANSGENIC MOUSE; TUMOR CELL LINE; WNT SIGNALING PATHWAY;

ACTINS; ANIMALS; BETA CATENIN; CELL LINE, TUMOR; DNA METHYLATION; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEART; HEART DEFECTS, CONGENITAL; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, TRANSGENIC; NATRIURETIC PEPTIDE, BRAIN; PROMOTER REGIONS, GENETIC; TROPONIN T; WNT SIGNALING PATHWAY;

EID: 84891661520     PISSN: 09628819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11248-013-9738-z     Document Type: Article

References (41)

1. Ai L, Tao Q, Zhong S, Fields CR, Kim WJ, Lee MW, Cui Y, Brown KD, Robertson KD (2006) Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer. Carcinogenesis 27: 1341-1348.
2. Buermans HP, van Wijk B, Hulsker MA, Smit NC, den Dunnen JT, van Ommen GB, Moorman AF, van den Hoff MJ, 't Hoen PA (2010) Comprehensive gene-expression survey identifies wif1 as a modulator of cardiomyocyte differentiation. PLoS ONE 5: e15504.
3. Chan SL, Cui Y, van Hasselt A, Li H, Srivastava G, Jin H, Ng KM, Wang Y, Lee KY, Tsao GS, Zhong S, Robertson KD, Rha SY, Chan AT, Tao Q (2007) The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas. Lab Invest 87: 644-650.
4. Clément G, Guilleret I, He B, Yagui-Beltrán A, Lin YC, You L, Xu Z, Shi Y, Okamoto J, Benhattar J, Jablons D (2008) Epigenetic alteration of the Wnt inhibitory factor-1 promoter occurs early in the carcinogenesis of Barrett's esophagus. Cancer Sci 99: 46-53.
5. Cohen ED, Tian Y, Morrisey EE (2008) Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal. Development 135: 789-798.
6. Crawford K, Flick R, Close L, Shelly D, Paul R, Bove K, Kumar A, Lessard J (2002) Mice lacking skeletal muscle actin show reduced muscle strength and growth deficits and die during the neonatal period. Mol Cell Biol 22: 5887-5896.
7. Dan L, Hong L, Xiaojuan Z, Haitao S, Lan H, Chuan Q, Lianfeng Z (2010) LMNA E82 K mutation activates FAS and mitochondrial pathways of apoptosis in heart tissue specific transgenic mice. PLoS ONE 5: e15167.
8. Ding Z, Qian YB, Zhu LX, Xiong QR (2009) Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma. World J Gastroenterol 15: 2595-2601.
9. Feng JJ, Marston S (2009) Genotype-phenotype correlations in ACTA1 mutations that cause congenital myopathies. Neuromuscul Disord 19: 6-16.
10. Hsieh JC, Kodjabachian L, Rebbert ML, Rattner A, Smallwood PM, Samos CH, Nusse R, Dawid IB, Nathans J (1999) A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 398: 431-436.
11. Hu YA, Zhao CJ (2010) Research progress of Wif1 in development of nervous system. Zhejiang Da Xue Xue Bao Yi Xue Ban 39: 93-96.
12. Hu YA, Gu X, Liu J, Yang Y, Yan Y, Zhao C (2008) Expression pattern of Wnt inhibitor factor 1 (Wif1) during the development in mouse CNS. Gene Expr Patterns 8: 515-522.
13. Hunter DD, Zhang M, Ferguson JW, Koch M, Brunken WJ (2004) The extracellular matrix component WIF-1 is expressed during, and can modulate, retinal development. Mol Cell Neurosci 27: 477-488.
14. Hurlstone AF, Haramis AP, Wienholds E, Begthel H, Korving J, van Eeden F, Cuppen E, Zivkovic D, Plasterk RH, Clevers H (2003) The Wnt/beta-catenin pathway regulates cardiac valve formation. Nature 425: 633-637.
15. Javadpour MM, Tardiff JC, Pinz I, Ingwall JS (2003) Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T. J Clin Invest 112: 768-775.
16. Juan F, Wei D, Xiongzhi Q, Ran D, Chunmei M, Lan H, Chuan Q, Lianfeng Z (2008) The changes of the cardiac structure and function in cTnTR141 W transgenic mice. Int J Cardiol 128: 83-90.
17. Kawano Y, Kypta R (2003) Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116: 2627-2634.
18. Kim J, You L, Xu Z, Kuchenbecker K, Raz D, He B, Jablons D (2007) Wnt inhibitory factor inhibits lung cancer cell growth. J Thorac Cardiovasc Surg 133: 733-737.
19. Lanfear DE, Stolker JM, Marsh S, Rich MW, McLeod HL (2007) Genetic variation in the B-type natiuretic peptide pathway affects BNP levels. Cardiovasc Drugs Ther 21: 55-62.
20. Lin YC, You L, Xu Z, He B, Yang CT, Chen JK, Mikami I, Clément G, Shi Y, Kuchenbecker K, Okamoto J, Kashani-Sabet M, Jablons DM (2007) Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth. Hum Gene Ther 18: 379-386.
21. Liu J, Lam JB, Chow KH, Xu A, Lam KS, Moon RT, Wang Y (2008) Adiponectin stimulates Wnt inhibitory factor-1 expression through epigenetic regulations involving the transcription factor specificity protein 1. Carcinogenesis 29: 2195-2202.
22. Lu D, Ma Y, Zhang W, Bao D, Dong W, Lian H, Huang L, Zhang L (2012) Knockdown of cytochrome P450 2E1 inhibits oxidative stress and apoptosis in the cTnTR141 W dilated cardiomyopathy transgenic mice. Hypertension 60: 81-89.
23. Macdonald BT, Semenov MV, He X (2007) SnapShot: Wnt/beta-catenin signaling. Cell 131: 1204.
24. MacDonald BT, Tamai K, He X (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9-26.
25. Malinauskas T, Aricescu AR, Lu W, Siebold C, Jones EY (2011) Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1. Nat Struct Mol Biol 18: 886-893.
26. Mazieres J, He B, You L, Xu Z, Lee AY, Mikami I, Reguart N, Rosell R, McCormick F, Jablons DM (2004) Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res 64: 4717-4720.
27. Moon RT, Bowerman B, Boutros M, Perrimon N (2002) The promise and perils of Wnt signaling through beta-catenin. Science 296: 1644-1646.
28. Nakamura T, Sano M, Songyang Z, Schneider MD (2003) A Wnt- and beta -catenin-dependent pathway for mammalian cardiac myogenesis. Proc Natl Acad Sci 100: 5834-5839.
29. Nakaya N, Lee HS, Takada Y, Tzchori I, Tomarev SI (2008) Zebrafish olfactomedin 1 regulates retinal axon elongation in vivo and is a modulator of Wnt signaling pathway. J Neurosci 28: 7900-7910.
30. Park JI, Kim SW, Lyons JP, Ji H, Nguyen TT, Cho K, Barton MC, Deroo T, Vleminckx K, Moon RT, McCrea PD (2005) Kaiso/p120-catenin and TCF/beta-catenin complexes coordinately regulate canonical Wnt gene targets. Dev Cell 8: 843-854.
31. Semenov MV, Habas R, Macdonald BT, He X (2007) SnapShot: noncanonical Wnt signaling pathways. Cell 131: 1378.
32. Surmann-Schmitt C, Widmann N, Dietz U, Saeger B, Eitzinger N, Nakamura Y, Rattel M, Latham R, Hartmann C, von der Mark H, Schett G, von der Mark K, Stock M (2009) Wif-1 is expressed at cartilage-mesenchyme interfaces and impedes Wnt3a-mediated inhibition of chondrogenesis. J Cell Sci 122: 3627-3637.
33. Tamura N, Ogawa Y, Chusho H, Nakamura K, Nakao K, Suda M, Kasahara M, Hashimoto R, Katsuura G, Mukoyama M, Itoh H, Saito Y, Tanaka I, Otani H, Katsuki M (2000) Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci USA 97: 4239-4244.
34. Tang Y, Simoneau AR, Liao WX, Yi G, Hope C, Liu F, Li S, Xie J, Holcombe RF, Jurnak FA, Mercola D, Hoang BH, Zi X (2009) WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells. Mol Cancer Ther 8: 458-468.
35. Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai K, Shinomura Y (2005) Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers. Oncogene 24: 7946-7952.
36. Tardiff JC, Hewett TE, Palmer BM, Olsson C, Factor SM, Moore RL, Robbins J, Leinwand LA (1999) Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy. J Clin Invest 104: 469-481.
37. Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, Seidman JG, Seidman CE (1994) Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77: 701-712.
38. Tsybouleva N, Zhang L, Chen S, Patel R, Lutucuta S, Nemoto S, DeFreitas G, Entman M, Carabello BA, Roberts R, Marian AJ (2004) Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy. Circulation 109: 1284-1291.
39. Urakami S, Shiina H, Enokida H, Kawakami T, Tokizane T, Ogishima T, Tanaka Y, Li LC, Ribeiro-Filho LA, Terashima M, Kikuno N, Adachi H, Yoneda T, Kishi H, Shigeno K, Konety BR, Igawa M, Dahiya R (2006) Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/β-catenin signaling pathway. Clin Cancer Res 12: 383-391.
40. Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG et al (1995) Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 332: 1058-1064.
41. Wissmann C, Wild PJ, Kaiser S, Roepcke S, Stoehr R, Woenckhaus M, Kristiansen G, Hsieh JC, Hofstaedter F, Hartmann A, Knuechel R, Rosenthal A, Pilarsky C (2003) WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol 201: 204-212.